跳至主要内容
临床试验/JPRN-UMIN000018714
JPRN-UMIN000018714招募中未知

Pharmacokinetics and safety of teriparatide in dialysis patients with osteoporosis - TERIYAKI study (teriparatide therapy in osteoporosis patients with end stage kidney disease)

Osaka University Graduate School of Medicine0 个研究点目标入组 20 人开始时间: 2015年8月18日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 100years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • *Patients with asthmatic diathesis and *Patients who develop a rash or symptom of irritation easily *Patients out of the reference ranges of ionized calcium or corrected calcium *Pregnant patients *Patients with severe cardiac or hepatic disease *Patients with dementia or psychiatric disease *Transplant recipients *Patients whose doses or kinds of antihypertensive drug were changed within the previous 2 weeks *Patients with high risk of osteosarcoma *Patients with primary or metastatic bone tumor *Patients who had been treated with teriparatide over 72 weeks *Patients regarded as inappropriate by researchers

研究者

相似试验

Pharmacokinetics and safety of teriparatide in... | 临床试验